Diabetic retinopathy treatment with Stem Cell Application

Diabetic Retinopathy stem cell applicationIn diabetic retinopathy the retina becomes damaged due to long-term diabetes. The retina is a tissue that is situated at the back of the eye and it converts received images into nerve signals before delivering them to the brain.
Diabetic retinopathy occurs when the blood vessels of the retina become damaged. Nonproliferative diabetic retinopathy refers to the early stages of the disease where blood vessels in the eye form microaneurysms, which means they are enlarged in certain areas. They can also become blocked.

The more severe and advanced stage of the disease is called proliferative retinopathy. New blood vessels appear in the eye, causing increasingly poor vision and other symptoms. Diabetic retinopathy symptoms range from blurred vision and gradual vision loss to shadows, missing sections of vision and difficulty seeing at night.

The number one cause of blindness in Americans of working age is diabetic retinopathy. Both type 1 and type 2 diabetes patients are at risk of developing the condition. The longer someone has had diabetes the more likely they are to develop diabetic retinopathy. Poorly managed diabetes tends to make diabetic retinopathy more severe and occur earlier. Most people who have had diabetes for over 30 years present symptoms of diabetic retinopathy.

New Stem Cell Application treats Patients with Diabetic Retinopathy


With an amazing capacity to remodel themselves, adult stem cells are also undifferentiated and can mutate into a multitude of organs in the patient’s body. Vital in many treatments they reconstruct damaged tissues and rehabilitate deficient fibers through the rapid activity of cell division, whereby the stem cells multiply indefinitely. Our age has witnessed tremendous breakthroughs and findings and stem cell science continues to make strides in increasing its sophistication and relevance to our health.

The Adult Autologous Stem Cell (A-ASC ) Therapy program


The Adult Autologous Stem Cell (A-ASC ) Therapy program that Angeles Health has treats an array of health problems, including eye disease. Diabetic retinopathy is managed with stem cell application that uses autologous adult stem cells, indicating that the cells derive from the patient themselves. This means there is limited possibility of a patient’s body rejecting the stem cells.

The stem cells are harvested from the patient’s bone marrow and adipose tissue, or fat. Adipose tissue extraction is better than bone marrow extraction as the fiber holds more stem cells and can in fact produce up to ten times more. In addition bone marrow extraction is more difficult to perform.

The specialized catheterization procedure places stem cells as close as possible to the problematic tissues or organ. It is not invasive, nor does it exhaust the patient very much. Stem cells can be distributed throughout the body, there is no anesthesia used and the procedure is finished within an hour.

Treatment at Angeles Health International is high quality and innovative with diabetic retinopathy patients treated in confidence at our Center of Excellence. Doctors work and learn together to identify best practice, create treatment protocols and evaluate findings. Multi-disciplinary teams of health care professionals keep to the codes and guidelines set out by official boards of medical expertise. Exceptional treatment standards and research quality are thus continued.

Contact Angeles Hospital!


Fill in the form on your right to get in touch with us and discover the possibilities of Stem Cell Application at our leading hospital in Mexico.